ClinicalTrials.gov research-record snapshot for Indianapolis, IN
Snapshot scope: This page is a static ClinicalTrials.gov research-record snapshot retrieved on . The fixed source query returned 23 results; after an exact city/state check of listed facilities, 23 records were retained for Indianapolis, Indiana. It is not a clinic, enrollment, or local-availability directory.
Snapshot methodology and exact-location matching
City/state source filter
Indianapolis, Indiana
Exact-location inclusion rule
A listed facility city and state must match Indianapolis, Indiana.
Records are retained only after the listed facility location matches the fixed city and state. This location match does not establish enrollment, site activity, eligibility, or local availability.
Fixed query terms
semaglutide
tirzepatide
cagrilintide
retatrutide
tesamorelin
sermorelin
ipamorelin
bpc-157
thymosin alpha 1
pt-141
Included study statuses
RECRUITING
NOT_YET_RECRUITING
ACTIVE_NOT_RECRUITING
ENROLLING_BY_INVITATION
How to read this snapshot
Research-record limits
This is not a clinic, enrollment, local-service, or local-availability directory.
Why Peptides does not recommend sites, assess eligibility, or provide medical advice.
A listing or study-level status does not prove enrollment, eligibility, safety, effectiveness, or availability.
Each displayed registry status is a study-level overall status, not a facility enrollment status.
Links on this page lead only to the cited ClinicalTrials.gov source records and search pages.
Records are a fixed snapshot, not a complete or live catalog.
All retained records
Study-level status mix
The counts below summarize every retained record in this snapshot. They describe registry study status only, not whether a particular facility is enrolling.
RECRUITING
7 records
NOT_YET_RECRUITING
4 records
ACTIVE_NOT_RECRUITING
11 records
ENROLLING_BY_INVITATION
1 record
Records in this snapshot
Retained ClinicalTrials.gov NCT records
The retrieved source snapshot contains 23 exact-location records and 11 listed facilities. All 23 retained records are shown below.
Registry title: Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Study-level overall status
RECRUITING
Record update date
Exact-matched listed facility/location
Indiana University Health University HospitalIndianapolis, Indiana 46202
Registry title: Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Study-level overall status
RECRUITING
Record update date
Exact-matched listed facility/location
Indiana University Health University HospitalIndianapolis, Indiana 46202
Registry title: A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Study-level overall status
NOT_YET_RECRUITING
Record update date
Exact-matched listed facility/location
Midwest Inst For Clin ResIndianapolis, Indiana 46260
Registry title: A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Study-level overall status
RECRUITING
Record update date
Exact-matched listed facility/location
Dawes Fretzin Clinical Research Group, LLCIndianapolis, Indiana 46250
Registry title: STEP TEENS Weight Maintenance: A Research Study on How Well Semaglutide Helps Teenagers With Excess Body Weight to Lose Weight and Maintain Weight Loss
Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date
Exact-matched listed facility/location
Indiana University HospitalIndianapolis, Indiana 46505
Registry title: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Study-level overall status
NOT_YET_RECRUITING
Record update date
Exact-matched listed facility/location
Riley Hospital For ChildrenIndianapolis, Indiana 46202
Registry title: A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Study-level overall status
ACTIVE_NOT_RECRUITING
Record update date
Exact-matched listed facility/location
Indiana University Health University HospitalIndianapolis, Indiana 46202
Registry title: Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide
Registry title: Fibrosis Lessens After Metabolic Surgery
Study-level overall status
RECRUITING
Record update date
Exact-matched listed facility/location
Indiana UniversityIndianapolis, Indiana 46202
Source retrieval and snapshot limits
Source-query results versus exact-location records
At retrieval, the fixed ClinicalTrials.gov source query returned 23 results. After an exact city/state check of listed facilities, 23 records were retained for Indianapolis, Indiana, across 11 listed facilities. All 23 retained records are shown on this page.
Source retrieved
Record update dates
Shown for each displayed NCT record, as supplied by ClinicalTrials.gov
Live search scope: This broader live search does not reproduce the included-status filter used for this snapshot, so it can show other study statuses and change after source retrieval.
Snapshot limits: The retrieval timestamp records when Why Peptides retrieved the ClinicalTrials.gov source query; it is not an independent validation. Record update dates are supplied by ClinicalTrials.gov and can differ from the retrieval timestamp. This static snapshot is not a complete or live catalog and can become stale. Why Peptides has not independently validated record details, facilities, enrollment, contacts, eligibility, or site status. For a displayed study, open its linked ClinicalTrials.gov NCT record for current contacts, eligibility, and site status.